SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home » Brochures
Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.
Syngene offers comprehensive translational and clinical research services, including over 800 BA/BE, PK/PD, and phase I-III trials, with deep expertise in oncology, diabetes, and autoimmune disorders.
Syngene offers integrated and standalone services across the drug discovery continuum from Target Identification to IND enabling.
Syngene’s offers an end-to-end platform to deliver integrated and standalone services for small molecules across the Development continuum.
Syngene offers end‑to‑end biologics services across a broad range of modalities and therapeutic areas, including mAbs, recombinant proteins, bispecifics, biosimilars, and antibody–drug conjugates (ADCs).